Showing results (211-220 of 279) with videos related to
Sort By:
Pageof 28
Clinical Journal of the American Society of Nephrology : CJASN|January 22, 2010
The HALT polycystic kidney disease trials: design and implementationArlene B Chapman, Vicente E Torres, Ronald D Perrone, et al.Kidney International|December 21, 2016
Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney diseaseVicente E Torres, Kaleab Z Abebe, Robert W Schrier, et al.Journal of the American Heart Association|December 31, 2017
Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and LipidomicsMohamed H Shahin, Yan Gong, Reginald F Frye, et al.Kidney International|February 3, 2023
Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentationAdriana V Gregory, Fouad T Chebib, Bhavya Poudyal, et al.Hypertension (Dallas, Tex. : 1979)|September 6, 2012
G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertensionAlexander G Vandell, Maximilian T Lobmeyer, Brian E Gawronski, et al.BMC Medical Genomics|June 22, 2018
Blood pressure signature genes and blood pressure response to thiazide diuretics: results from the PEAR and PEAR-2 studiesAna Caroline C Sá, Amy Webb, Yan Gong, et al.Clinical Journal of the American Society of Nephrology : CJASN|February 21, 2012
Kidney volume and functional outcomes in autosomal dominant polycystic kidney diseaseArlene B Chapman, James E Bost, Vicente E Torres, et al.American Journal of Human Genetics|December 7, 2010
Temtamy preaxial brachydactyly syndrome is caused by loss-of-function mutations in chondroitin synthase 1, a potential target of BMP signalingYun Li, Kathrin Laue, Samia Temtamy, et al.JCI Insight|December 22, 2025
Inhibition of cell surface GRP78 and activated α2M interaction attenuates kidney fibrosisJackie Trink, Ifeanyi Kennedy Nmecha, Katrine Pilely, et al.Kidney International Reports|April 29, 2021
Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney DiseaseMireille El Ters, Pengcheng Lu, Jonathan D Mahnken, et al.Pageof 28